VIDAS^® Fertility panel

The VIDAS^® Fertility panel provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia and azoospermia. In assisted reproductive technologies (ART), correct diagnosis of the cause of infertility is a pre-requisite to successful treatment. In addition, our hormone tests are essential monitoring tools in IVF protocols. They contribute to the optimization of individual patient treatment for increased chances of success and greater patient comfort.

Hormone testing in ART

Hormone measurements are essential to personalize treatment of infertility and monitor the progress of ovarian stimulation.

Before treatment, they allow to identify the type of ovulation disorder and know the patient’s ovarian reserve.

During treatment, they are used to check compliance, optimize drug doses, and avoid futile embryo replacements and severe complications.

 

Hormone assays in the diagnosis and treatment of infertility

Click to enlarge

Reliable and robust AMH assay

The new VIDAS^® AMH assay offers on-hand quality testing for confident decisions:

• Reliable results when compared with an existing automated method*
• Patented proprietary raw materials for minimal impact of the pre-analytical stage on test results: up to 3 freezing/thawing cycles possible

In the context of infertility management, immediate integration of AMH measurements into the full diagnostic work-up allows to reduce patient stress, avoid unnecessary ovarian stimulation and reduce the risk of hyperstimulation syndrome.

Precise and sensitive tools

Clinical evaluation of the VIDAS^® Estradiol and VIDAS^® Progesterone assays has confirmed their reliability for use in evaluating natural cycles and monitoring ovarian superovulation¹:

• Accuracy in the low concentration range to confirm pituitary suppression after GnRH-agonist therapy

• Strong correlation between serum estradiol measured by VIDAS^® Estradiol and follicular measurements by ultrasonography during gonadotropin treatment with both GnRH analogue protocols

Testing made simple for fertility clinics

Easy-to-use solution:

• No need for water
• All-inclusive reagent kits with ready-to-use reagents
• Just Load & Go
• No need for complex training
• Easy maintenance
• Robust instrument: MTBF > 700 days

Enables on-site testing for key advantages:

• Rapid results
• Faster adaptation of stimulation treatment
• Cost-effectiveness

Fertility, thyroid and serology testing can be performed on the same instrument:

• Broad VIDAS^® test menu including HIV, hepatitis, toxoplasmosis, rubella, CMV, TSH, FT3, FT4 and Anti-TPO

Note

* See package insert

 

Reference

1. E. Anckaert et al. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS^®) for Use in Monitoring Assisted Reproduction Treatment. Clin Chem Lab Med 2002; 40(8):824-831.